AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

MarketsSign up free
🇹🇳

AMLODIPINE+VALSARTAN+HYDROCHLOROTHIAZIDE in Tunisia

7 products registered with DPM — 0 active, 7 expired

Brand / ProductReg. No.HolderStatusExpires
DUOFOR PLUS
Comprimé pelliculé / 5mg/160mg/12.5 mg
9353271PHILADELPHIA PHARMAexpired16 Feb 2021
DUOFOR PLUS
Comprimé pelliculé / 10 mg/160mg/12.5mg
9353272PHILADELPHIA PHARMAexpired16 Feb 2021
DUOFOR PLUS
Comprimé pelliculé / 5mg/160mg/25 mg
9353273PHILADELPHIA PHARMAexpired16 Feb 2021
EXFORGE HCT
Comprimé pelliculé / 5 mg/160mg/12.5mg
10283208NOVARTIS PHARMA SCHWEIZ AGexpired17 Feb 2015
EXFORGE HCT
Comprimé pelliculé / 10 mg/160mg/12.5mg
10283207NOVARTIS PHARMA SCHWEIZ AGexpired17 Feb 2015
EXFORGE HCT
Comprimé pelliculé / 10 mg/160mg/25mg
10283205NOVARTIS PHARMA SCHWEIZ AGexpired16 Feb 2015
EXFORGE HCT
Comprimé pelliculé / 5 mg/160mg/25mg
10283206NOVARTIS PHARMA SCHWEIZ AGexpired16 Feb 2015

AMLODIPINE+VALSARTAN+HYDROCHLOROTHIAZIDE — DPM Registration Details

DPM (Tunisia) has 7 registered products containing AMLODIPINE+VALSARTAN+HYDROCHLOROTHIAZIDE, of which 0 are currently active. Data is sourced directly from the official DPM drug register and refreshed daily.

Track AMLODIPINE+VALSARTAN+HYDROCHLOROTHIAZIDE registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.